DE69321218D1 - Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4 - Google Patents
Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4Info
- Publication number
- DE69321218D1 DE69321218D1 DE69321218T DE69321218T DE69321218D1 DE 69321218 D1 DE69321218 D1 DE 69321218D1 DE 69321218 T DE69321218 T DE 69321218T DE 69321218 T DE69321218 T DE 69321218T DE 69321218 D1 DE69321218 D1 DE 69321218D1
- Authority
- DE
- Germany
- Prior art keywords
- human interleukin
- pct
- monoclonal antibodies
- cloning
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
- C07K16/464—Igs containing CDR-residues from one specie grafted between FR-residues from another
- C07K16/465—Igs containing CDR-residues from one specie grafted between FR-residues from another with additional modified FR-residues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/247—IL-4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84165992A | 1992-02-19 | 1992-02-19 | |
PCT/US1993/001301 WO1993017106A1 (en) | 1992-02-19 | 1993-02-18 | Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69321218D1 true DE69321218D1 (de) | 1998-10-29 |
DE69321218T2 DE69321218T2 (de) | 1999-02-18 |
Family
ID=25285411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69321218T Expired - Fee Related DE69321218T2 (de) | 1992-02-19 | 1993-02-18 | Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4 |
Country Status (18)
Country | Link |
---|---|
US (2) | US5863537A (de) |
EP (1) | EP0627002B1 (de) |
JP (1) | JPH07502901A (de) |
KR (1) | KR0158240B1 (de) |
CN (1) | CN1076966A (de) |
AT (1) | ATE171472T1 (de) |
AU (1) | AU684041B2 (de) |
CA (1) | CA2130436C (de) |
DE (1) | DE69321218T2 (de) |
DK (1) | DK0627002T3 (de) |
ES (1) | ES2121078T3 (de) |
HK (1) | HK1008831A1 (de) |
IL (1) | IL104782A0 (de) |
MX (1) | MX9300913A (de) |
NZ (1) | NZ249677A (de) |
SG (1) | SG52215A1 (de) |
WO (1) | WO1993017106A1 (de) |
ZA (1) | ZA931148B (de) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69321218T2 (de) * | 1992-02-19 | 1999-02-18 | Schering Corp | Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4 |
EP0604693A1 (de) * | 1992-12-29 | 1994-07-06 | Schering-Plough | Monoklonale Antikörper gegen den menschlichen Interleukin-4-Rezeptor und Hybridomen die diese produzieren |
US5928904A (en) * | 1993-09-07 | 1999-07-27 | Smithkline Beecham Corporation | DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders |
ATE286510T1 (de) * | 1993-09-07 | 2005-01-15 | Smithkline Beecham Corp | In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper |
US5914110A (en) * | 1993-09-07 | 1999-06-22 | Smithkline Beecham Corporation | Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders |
US20020193575A1 (en) * | 1993-09-07 | 2002-12-19 | Smithkline Beecham P.L.C. | Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders |
US5597710A (en) * | 1994-03-10 | 1997-01-28 | Schering Corporation | Humanized monoclonal antibodies against human interleukin-4 |
GB9412230D0 (en) * | 1994-06-17 | 1994-08-10 | Celltech Ltd | Interleukin-5 specific recombiant antibodies |
US5705154A (en) * | 1995-03-08 | 1998-01-06 | Schering Corporation | Humanized monoclonal antibodies against human interleukin-4 |
BR9911882A (pt) | 1998-07-13 | 2005-02-15 | Univ Texas | Processo de tratamento de câncer empregando anticorpos a aminofosfolipìdios |
WO2000052516A2 (en) * | 1999-03-01 | 2000-09-08 | Boston Innovative Optics, Inc. | System and method for increasing the depth of focus of the human eye |
EP1283851B1 (de) | 2000-05-26 | 2012-03-28 | Immunex Corporation | VERWENDUNG VON ANTIKöRPER GEGEN INTERLEUKIN-4 REZEPTOR UND DEREN ZUSAMMENSETZUNGEN |
US7893218B2 (en) | 2003-06-16 | 2011-02-22 | Stowers Institute For Medical Research | Antibodies that specifically bind SOST peptides |
US20070104710A1 (en) * | 2002-06-28 | 2007-05-10 | Domants Limited | Ligand that has binding specificity for IL-4 and/or IL-13 |
KR101257584B1 (ko) | 2002-07-15 | 2013-04-23 | 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 | 음이온성 인지질 및 아미노인지질에 결합하는 선택된 항체 및 치료하는데 있어서 이의 용도 |
EP1629090B1 (de) * | 2002-11-06 | 2014-03-05 | iBio, Inc. | Expression von fremdsequenzen in pflanzen unter verwendung eines trans-aktivierungssystems |
US7692063B2 (en) * | 2002-11-12 | 2010-04-06 | Ibio, Inc. | Production of foreign nucleic acids and polypeptides in sprout systems |
US7683238B2 (en) * | 2002-11-12 | 2010-03-23 | iBio, Inc. and Fraunhofer USA, Inc. | Production of pharmaceutically active proteins in sprouted seedlings |
US7491509B2 (en) | 2003-02-03 | 2009-02-17 | Fraunhofer Usa, Inc. | System for expression of genes in plants |
JP4741242B2 (ja) | 2002-11-26 | 2011-08-03 | アボット バイオセラピューティクス コーポレイション | 新脈管形成を調節するα5β1インテグリンへのキメラ及びヒト化抗体 |
US7276589B2 (en) * | 2002-11-26 | 2007-10-02 | Pdl Biopharma, Inc. | Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis |
US7285268B2 (en) * | 2002-11-26 | 2007-10-23 | Pdl Biopharma, Inc. | Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis |
US20110223168A1 (en) * | 2002-12-27 | 2011-09-15 | Greg Winter | Ligand that has binding specificity for il-4 and/or il-13 |
US20050002930A1 (en) * | 2003-04-03 | 2005-01-06 | Johnson Dale E. | Methods of production and use of anti-integrin antibodies for the control of tissue granulation |
ES2427641T3 (es) | 2003-05-22 | 2013-10-31 | Ibio, Inc. | Molécula vehículo recombinante para la expresión, el suministro y la purificación de polipéptidos diana |
US7628810B2 (en) * | 2003-05-28 | 2009-12-08 | Acufocus, Inc. | Mask configured to maintain nutrient transport without producing visible diffraction patterns |
US20050046794A1 (en) * | 2003-06-17 | 2005-03-03 | Silvestrini Thomas A. | Method and apparatus for aligning a mask with the visual axis of an eye |
ES2532609T3 (es) * | 2004-02-20 | 2015-03-30 | Ibio, Inc. | Sistemas y métodos para expresión clonales en plantas |
JP4857259B2 (ja) * | 2004-03-24 | 2012-01-18 | アボット バイオセラピューティクス コーポレイション | 癌細胞増殖を阻害するための抗α5β1抗体の使用 |
AR050044A1 (es) * | 2004-08-03 | 2006-09-20 | Novartis Ag | Anticuerpo especifico de il-4 |
US7976577B2 (en) | 2005-04-14 | 2011-07-12 | Acufocus, Inc. | Corneal optic formed of degradation resistant polymer |
WO2007117264A2 (en) * | 2005-08-03 | 2007-10-18 | Fraunhofer Usa, Inc. | Compositions and methods for production of immunoglobulins |
EA200801515A1 (ru) * | 2006-01-24 | 2009-02-27 | Домантис Лимитед | Лиганды, которые связывают il-4 и/или il-13 |
CA2642056A1 (en) * | 2006-02-13 | 2007-08-23 | Fraunhofer Usa, Inc. | Hpv antigens, vaccine compositions, and related methods |
US8277816B2 (en) * | 2006-02-13 | 2012-10-02 | Fraunhofer Usa, Inc. | Bacillus anthracis antigens, vaccine compositions, and related methods |
JP2009526526A (ja) * | 2006-02-13 | 2009-07-23 | フラウンホーファー ユーエスエー, インコーポレイテッド | インフルエンザ抗原、ワクチン組成物、および関連する方法 |
US7608693B2 (en) * | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
ES2930183T3 (es) | 2006-12-29 | 2022-12-07 | Ossifi Mab Llc | Métodos para alterar el crecimiento óseo mediante la administración del antagonista o agonista de Sost o Wise |
CA2685558A1 (en) * | 2007-04-28 | 2008-11-06 | Fraunhofer Usa, Inc. | Trypanosoma antigens, vaccine compositions, and related methods |
EP2178558B1 (de) * | 2007-07-11 | 2014-04-30 | iBio, Inc. | Yersinia pestis-antigene, impfstoffzusammensetzungen und zugehörige verfahren |
AU2008282331A1 (en) * | 2007-07-27 | 2009-02-05 | Facet Biotech Corporation | Pharmaceutical combinations comprising a tyrosine kinase inhibitor and an antibody against integrin alpha 1 beta 5 (CD49E) |
WO2010037046A1 (en) | 2008-09-28 | 2010-04-01 | Fraunhofer Usa, Inc. | Humanized neuraminidase antibody and methods of use thereof |
US9309325B2 (en) | 2009-05-07 | 2016-04-12 | The Regents Of The University Of California | Antibodies and methods of use thereof |
BR112012008083A2 (pt) | 2009-08-13 | 2016-04-19 | Acufocus Inc | lentes e implantes intraoculares ocultos |
WO2011041391A1 (en) | 2009-09-29 | 2011-04-07 | Fraunhofer Usa, Inc. | Influenza hemagglutinin antibodies, compositions, and related methods |
USD656526S1 (en) | 2009-11-10 | 2012-03-27 | Acufocus, Inc. | Ocular mask |
WO2013009767A2 (en) | 2011-07-12 | 2013-01-17 | Epitomics, Inc. | Facs-based method for obtaining an antibody sequence |
WO2013082545A1 (en) | 2011-12-02 | 2013-06-06 | Acufocus, Inc. | Ocular mask having selective spectral transmission |
CA2890190A1 (en) | 2012-11-12 | 2014-05-15 | Redwood Bioscience, Inc. | Compounds and methods for producing a conjugate |
US9310374B2 (en) | 2012-11-16 | 2016-04-12 | Redwood Bioscience, Inc. | Hydrazinyl-indole compounds and methods for producing a conjugate |
EP2920148B1 (de) | 2012-11-16 | 2019-06-12 | The Regents of the University of California | Pictet-spengler-ligation zur chemischen proteinmodifizierung |
US9204962B2 (en) | 2013-03-13 | 2015-12-08 | Acufocus, Inc. | In situ adjustable optical mask |
US9302005B2 (en) | 2013-03-14 | 2016-04-05 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
US9427922B2 (en) | 2013-03-14 | 2016-08-30 | Acufocus, Inc. | Process for manufacturing an intraocular lens with an embedded mask |
CN103421747B (zh) * | 2013-09-09 | 2015-01-07 | 扬州大学 | 分泌牛il-4单克隆抗体的杂交瘤细胞株、其单克隆抗体及其应用 |
EP3470081A1 (de) | 2013-10-01 | 2019-04-17 | Mayo Foundation for Medical Education and Research | Verfahren zur behandlung von krebs bei patienten mit erhöhten bim-werten |
CA3178867A1 (en) | 2013-11-27 | 2015-06-04 | Redwood Bioscience, Inc. | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate |
US10302653B2 (en) | 2014-05-22 | 2019-05-28 | Mayo Foundation For Medical Education And Research | Distinguishing antagonistic and agonistic anti B7-H1 antibodies |
CA2947484C (en) | 2014-06-06 | 2023-05-09 | Redwood Bioscience, Inc. | Anti-her2 antibody-maytansine conjugates and methods of use thereof |
WO2016014148A1 (en) | 2014-07-23 | 2016-01-28 | Mayo Foundation For Medical Education And Research | Targeting dna-pkcs and b7-h1 to treat cancer |
ES2822228T3 (es) | 2014-10-24 | 2021-04-29 | Univ Leland Stanford Junior | Composiciones y métodos para inducir la fagocitosis de células positivas de clase I de CMH y contrarrestar la resistencia a anti-CD47/SIRPA |
WO2016081455A1 (en) | 2014-11-17 | 2016-05-26 | Pelican Therapeutics, Inc. | Human tnfrsf25 antibody |
US10875923B2 (en) | 2015-10-30 | 2020-12-29 | Mayo Foundation For Medical Education And Research | Antibodies to B7-H1 |
WO2017079419A1 (en) | 2015-11-05 | 2017-05-11 | The Regents Of The University Of California | Cells labelled with lipid conjugates and methods of use thereof |
RU2746314C2 (ru) | 2016-06-09 | 2021-04-12 | Пеликан Терапьютикс, Инк. | Антитела анти-tnfrsf25 |
US10240581B2 (en) | 2017-02-08 | 2019-03-26 | General Electric Company | System and method for controlling pitch angle of a wind turbine rotor blade |
CN110540590B (zh) * | 2018-05-29 | 2023-08-18 | 康诺亚生物医药科技(成都)有限公司 | 一种自免疫抑制物的开发和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5041381A (en) * | 1986-07-03 | 1991-08-20 | Schering Corporation | Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
IL89489A0 (en) * | 1988-03-09 | 1989-09-10 | Hybritech Inc | Chimeric antibodies directed against human carcinoembryonic antigen |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
GB9105292D0 (en) * | 1991-03-13 | 1991-04-24 | Sandoz Ltd | Improvements in or relating to organic compounds |
DE69321218T2 (de) * | 1992-02-19 | 1999-02-18 | Schering Corp | Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4 |
-
1993
- 1993-02-18 DE DE69321218T patent/DE69321218T2/de not_active Expired - Fee Related
- 1993-02-18 KR KR1019940702925A patent/KR0158240B1/ko not_active IP Right Cessation
- 1993-02-18 EP EP93905927A patent/EP0627002B1/de not_active Expired - Lifetime
- 1993-02-18 JP JP5514908A patent/JPH07502901A/ja active Pending
- 1993-02-18 IL IL104782A patent/IL104782A0/xx unknown
- 1993-02-18 ZA ZA931148A patent/ZA931148B/xx unknown
- 1993-02-18 US US08/290,793 patent/US5863537A/en not_active Expired - Lifetime
- 1993-02-18 NZ NZ249677A patent/NZ249677A/en unknown
- 1993-02-18 AT AT93905927T patent/ATE171472T1/de not_active IP Right Cessation
- 1993-02-18 DK DK93905927T patent/DK0627002T3/da active
- 1993-02-18 SG SG1996000536A patent/SG52215A1/en unknown
- 1993-02-18 WO PCT/US1993/001301 patent/WO1993017106A1/en active IP Right Grant
- 1993-02-18 AU AU36662/93A patent/AU684041B2/en not_active Ceased
- 1993-02-18 ES ES93905927T patent/ES2121078T3/es not_active Expired - Lifetime
- 1993-02-18 CA CA002130436A patent/CA2130436C/en not_active Expired - Fee Related
- 1993-02-19 CN CN93103442A patent/CN1076966A/zh active Pending
- 1993-02-19 MX MX9300913A patent/MX9300913A/es not_active IP Right Cessation
-
1995
- 1995-06-06 US US08/469,557 patent/US5770403A/en not_active Expired - Lifetime
-
1998
- 1998-07-29 HK HK98109512A patent/HK1008831A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MX9300913A (es) | 1994-08-31 |
AU684041B2 (en) | 1997-12-04 |
US5770403A (en) | 1998-06-23 |
ZA931148B (en) | 1993-08-18 |
KR950700414A (ko) | 1995-01-16 |
CA2130436A1 (en) | 1993-09-02 |
DE69321218T2 (de) | 1999-02-18 |
KR0158240B1 (ko) | 1998-11-16 |
EP0627002B1 (de) | 1998-09-23 |
US5863537A (en) | 1999-01-26 |
SG52215A1 (en) | 1998-09-28 |
ATE171472T1 (de) | 1998-10-15 |
EP0627002A1 (de) | 1994-12-07 |
AU3666293A (en) | 1993-09-13 |
NZ249677A (en) | 1996-08-27 |
CN1076966A (zh) | 1993-10-06 |
HK1008831A1 (en) | 1999-05-21 |
WO1993017106A1 (en) | 1993-09-02 |
DK0627002T3 (da) | 1999-06-14 |
IL104782A0 (en) | 1993-06-10 |
CA2130436C (en) | 2001-04-10 |
JPH07502901A (ja) | 1995-03-30 |
ES2121078T3 (es) | 1998-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69321218D1 (de) | Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4 | |
FI960567A0 (fi) | Monoklonaalinen vasta-aine, joka indusoi apoptoosin | |
DE69322860T2 (de) | Antikörper gegen alpha v beta 3 integrin | |
MY108526A (en) | Monoclonal antibodies against human interleukin-4 and hybridomas producing the same | |
ATE283926T1 (de) | Antikörper gegen die alpha-kette von humanem interleukin 5 rezeptor | |
PT778891E (pt) | Anticorpo monoclonal recombinante anti-rhesus d (d7c2) | |
ATE255902T1 (de) | Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv- verwandten krankheiten | |
DE69031410D1 (de) | Monoklonale Antikörper gegen den humanen alpha/beta-T-Zellenrezeptor, ihre Herstellung und Verwendung | |
DE69504959D1 (de) | Humanisierte monoklonale antikörper gegen humanes interleukin - 4 | |
FR2664702B1 (fr) | Procede de reduction d'interferences dans un dosage par fluorescence. | |
DK0802924T3 (da) | Lægemiddel til forlænget immunsuppression og eliminering af tumorceller | |
ATE206621T1 (de) | Il-8 antagonisten zur behandlung von asthma | |
DE59508137D1 (de) | Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |